Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
<p><strong>Introduction:</strong><br /> Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. Most such biomarker studies ar...
Principais autores: | Shi, L, Westwood, S, Baird, A, Winchester, L, Dobricic, V, Kilpert, F, Hong, S, Franke, A, Hye, A, Ashton, N, Morgan, A, Bos, I, Vos, S, Buckley, N, Kate, M, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, E, Sleegers, K, Frisoni, G, Blin, O, Richardson, J, Bordet, R, Molinuevo, J, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Zetterberg, H, Baker, S, Morgan, B, Streffer, J, Visser, P, Bertram, L, Lovestone, S, Nevado-Holgado, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2019
|
Registros relacionados
-
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
por: Westwood, S, et al.
Publicado em: (2020) -
Inflammatory biomarkers in Alzheimer's disease plasma
por: Morgan, A, et al.
Publicado em: (2019) -
Synaptic protein CSF levels relate to memory scores in individuals without dementia
por: Wesenhagen, KEJ, et al.
Publicado em: (2025) -
MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
por: ten Kate, M, et al.
Publicado em: (2018) -
Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
por: Delvenne, A, et al.
Publicado em: (2024)